2008
DOI: 10.1074/jbc.m704856200
|View full text |Cite
|
Sign up to set email alerts
|

PIKfyve Negatively Regulates Exocytosis in Neurosecretory Cells

Abstract: Regulated secretion depends upon a highly coordinated series of protein-protein and protein-lipid interactions. Two phosphoinositides, phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 3-phosphate, are important for the ATP-dependent priming of the secretory apparatus prior to Ca 2؉ -dependent exocytosis. Mechanisms that control phosphoinositide levels are likely to play an important role in priming fine tuning. Here we have investigated the involvement of PIKfyve, a phosphoinositide 5-kinase that… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
52
0

Year Published

2009
2009
2017
2017

Publication Types

Select...
6
4

Relationship

2
8

Authors

Journals

citations
Cited by 51 publications
(55 citation statements)
references
References 51 publications
3
52
0
Order By: Relevance
“…We showed that insulin stimulates the phosphorylation of Ser318 in cells and that this phosphorylation plays a role in GLUT4 trafficking because over-expression of the non-activatable PIKfyve[S318A] mutant in 3T3-L1 adipocytes enhanced insulin-stimulated GLUT4 vesicle translocation to the plasma membrane (Berwick et al 2004). This observation is consistent with recent studies showing that pharmacologic inhibition (using the selective PIKfyve inhibitor YM201636 ( Jefferies et al 2008)) and siRNA-mediated knockdown of PIKfyve both potentiate secretory granule exocytosis in chromaffin and PC12 cells (Osborne et al 2007). Together, however, these observations are not consistent with Shisheva's studies (Ikonomov et al 2002(Ikonomov et al , 2007 although care should be taken in interpreting experiments where PIKfyve activity has been disrupted by siRNA-mediated knockdown, a kinase-inactive mutant or the PIKfyve inhibitor YM201636 because these manipulations all cause vacuolation of intracellular membranes (Shisheva et al 2001, Rutherford et al 2006, Jefferies et al 2008.…”
Section: Pikfyvesupporting
confidence: 81%
“…We showed that insulin stimulates the phosphorylation of Ser318 in cells and that this phosphorylation plays a role in GLUT4 trafficking because over-expression of the non-activatable PIKfyve[S318A] mutant in 3T3-L1 adipocytes enhanced insulin-stimulated GLUT4 vesicle translocation to the plasma membrane (Berwick et al 2004). This observation is consistent with recent studies showing that pharmacologic inhibition (using the selective PIKfyve inhibitor YM201636 ( Jefferies et al 2008)) and siRNA-mediated knockdown of PIKfyve both potentiate secretory granule exocytosis in chromaffin and PC12 cells (Osborne et al 2007). Together, however, these observations are not consistent with Shisheva's studies (Ikonomov et al 2002(Ikonomov et al , 2007 although care should be taken in interpreting experiments where PIKfyve activity has been disrupted by siRNA-mediated knockdown, a kinase-inactive mutant or the PIKfyve inhibitor YM201636 because these manipulations all cause vacuolation of intracellular membranes (Shisheva et al 2001, Rutherford et al 2006, Jefferies et al 2008.…”
Section: Pikfyvesupporting
confidence: 81%
“…Expression of dominant-negative PIKfyve K1831E , or PIKfyve protein knockdown in mammalian cells, does not affect receptor internalization, Tfn recycling or receptor trafficking to lysosomes (Ikonomov et al, 2003;Rutherford et al, 2006). In mammalian cells, PIKfyve RNAi-mediated knockdown impairs early endosome-to-TGN traffic and potentiates exocytosis of neurosecretory vesicles (Rutherford et al, 2006;Osborne et al, 2008). However, we found that MTMR4 expression did not alter retrograde trafficking from early endosomes to the Golgi, as shown by the normal retrograde trafficking of cholera toxin from early endosomes to the Golgi (see supplementary material Fig.…”
Section: Discussionmentioning
confidence: 99%
“…In nociceptive pathways, an ideal drug to target the release of endogenous GFLs from LGVs could act e.g. onto the phosphatidylinositol-3-phosphate [PtdIns(3)P] pool, which is sensitive to Ca 2+ modulation [90].…”
Section: An Interesting Option For Developing New Drugs Is Thus Targementioning
confidence: 99%